Back to Search
VIRGINIA KLIMEK, MD
MD
Medical Oncology Physician
NPI: 1992776785Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
201211(NY)
Research & Publications (20)
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.
PMID 18245545·Clin Cancer Res·2008
3-trial
Serum levels of melanoma-inhibiting activity do not predict relapse in melanoma patients.
PMID 12607797·Cytokines Cell Mol Ther·2002
8-other
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.
PMID 18574442·Bone Marrow Transplant·2008
8-other
Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression.
PMID 18371940·Brain Res·2008
8-other
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
PMID 17893227·Blood·2008
3-trial
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
PMID 16532500·Cancer·2006
3-trial
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.
PMID 16319952·Leukemia·2006
3-trial
Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma.
PMID 16398649·Br J Haematol·2006
3-trial
Effect of smokeless tobacco extract on catecholamine metabolic enzymes in rat brain: "dippers" are getting only half of the bang.
PMID 16487666·Addict Behav·2006
7-preclinical
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications.
PMID 16569772·Blood·2006
8-other
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients.
PMID 16211386·Ann Hematol·2005
1-meta
Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML).
PMID 15345593·Blood·2005
7-preclinical
Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.
PMID 15862518·Brain Res·2005
8-other
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.
PMID 15345597·Blood·2005
3-trial
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial.
PMID 15640822·Bone Marrow Transplant·2005
3-trial
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial.
PMID 15124689·Ann Hematol·2004
3-trial
Elevated concentrations of CRF in the locus coeruleus of depressed subjects.
PMID 12784115·Neuropsychopharmacology·2003
4-observational
Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression.
PMID 12586450·Biol Psychiatry·2003
8-other
Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes.
PMID 12899717·Br J Haematol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1992776785
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile